Summary
Invasion of the vertebrate host by microorganisms or neoplastic cells triggers a variety of metabolic responses. One of them, the hypoferremic response, is the decrease in serum iron levels. This hypoferremia is observed not only during infections of various etiologies and neoplasia but also during trauma, myocardial infarction, surgery, and inflammation. The hypoferremic response thus appears to be a consistent and predictable biochemical response to pathogenesis. Hypoferremia has been shown to be of great protective value to the host against infection and neoplasia. Suppression of the iron-withholding ability of the host by excess iron is associated with a greater incidence and severity of infection and neoplasia. The potential therapeutic applications of the hypoferremic response are discussed.
Similar content being viewed by others
References
Wrigglesworth JM, Baum H: The Biochemical functions of iron. In: Jacob A, Worwood M (eds) Iron in Biochemistry and Medicine. Academic Press, New York, 1980, pp. 29–86
Forth W, Rummel W: Iron absorption. Physiol Rev 53: 724–292, 1973
Wheby MS. Suttle GE, Ford KT: Intestinal absorption of hemoglobin iron. Gastroenterology 58: 647–654, 1970
Bezkorovainy A: Chemistry and biology of iron storage. In: Frieden E (ed) Biochemistry of non-heme iron. Plenum Press, New York, 1980, pp 207–269
Aisen P: The transferrins. In: Jacob A, Worwood M (eds) Iron in Biochemistry and Medicine. Academic Press, New York, 1980, pp87–129
Aisen P, Listowsky I: Iron transport and storage proteins. Ann Rev Biochem 49: 357–393, 1980
Romslo I: Intracellular transport of iron. In: Jacob A, Worwood M (eds) Iron in Biochemistry and Medicine, Academic Press, New York, 1980, pp 325–362
Hershko C: Storage iron regulation. Prog Haematol X: 105–148, 1977
Lipschitz DA, Simon MO, Lynch SR, Dugard J, Bothwell TH: Some factors affecting the release of iron from reticulo-endothelial cells. Br J Hematol 21: 289–303, 1971
Harrison PM, Hoy TG, Hoare RJ: Towards a mechanism of iron uptake and release by ferritin molecules. In: Crichton RR (ed) Proteins of iron storage and transport in Biochemistry and Medicine. North Holland, Amsterdam, 1975, pp 271–278
Fillet G, Cook JD, Finch CA: Storage iron kinetics. VII. A biologic model for reticulo-endothelial iron transport. J Clin Invest 53: 1527–1533, 1974
Bothwell TH, Bradlow BA, Jacobs P: Iron metabolism in scurvy with special reference to erythropoiesis. Br J Hematol 10: 50–58, 1964
Wapnick AA, Bothwell TH, Seftel H: The relationship between serum iron levels and ascorbic acid stores in siderotic Bantu. Br J Hematol 19: 271–276, 1970
Frieden E, Hsieh S: Ceruloplasmin: the copper transport protein with essential oxidase activity. Adv Enzymol 45: 187–236, 1976
Neilands JB: Microbial metabolism of iron. In: Jacob A, Worwood M (eds) Iron in Biochemistry and Medicine. Academic Press, New York, 1980, pp 529–572
Light RA, Clegg RA: Metabolism in iron-limited growth. In: Neilands JB (ed) Microbial iron metabolism. Academic Press, New York, 1974, pp 35–64
Hunt J, richards J, Harwood R, Jacob A: The effect of desferroxiamine on fibroblasts and collagen formation in cell cultures. Br J Hematol 41: 69–76, 1979
Weinberg ED: Iron and infection. Microbiol Rev 42: 45–66, 1978
Neilands JB: Microbial iron compounds. Annu Rev Biochem 50: 715–731, 1981
Fernandez-Pol JA: Siderophore-like growth factor synthesis by transformed cells. Microbiology 1983: 313–317, 1983
Fernandez-Pol JA: Peptide and protein complexes of transition metals as Modulators of cellular replication. Int J Nucl Med Biol 8: 231–235, 1981
Brock JH, Rankin MC: Transferrin binding and iron up-take by mouse lymph node cells during transformation in response to concanavalin A. Immunology 43: 393–398, 1981
Frazier JL, Caskey JH, Yoffe M, Seligman PA: Studies of the transferrin receptor on both human reticulocytes and nucleated human cells in culture. J Clin Invest 69: 853–865, 1982
Galbraith GM, Galbraith RM, Faulk WP: Transferrin binding by human lymphoblastoid cell lines and other transformed cells. Cell Immunol 49: 215–222, 1980
Hamilton TA, Wada HG, Sussman HH: Identification of transferrin receptors on the surface of human cultured cells. Proc Natl Acad Sci USA 76: 6406–6410, 1979
Larrick JW, Cresswell P: Modulation of cell surface iron transferrin receptors by cellular density and state of activation. J Supramolec Struct 11: 579–586, 1979
Trowbridge IS, Omary MB: Human cell surface glycoprotein related to cell proliferation is the receptor for transferrin. Proc Natl Acad Sci USA 78: 3039–3043, 1981
Hu HY, Aisen P: Molecular characteristics of the transferrin receptor complex of the rabbit reticulocyte. J Supramolec Struct 8: 349–360, 1978
Weinberg ED: Iron and neoplasia. Biol Trace El Res 3: 55–80, 1981
Weinberg ED: Iron withholding: a defence against infection and neoplasia. Physiol Rev 64: 65–102
Pekarek RS, Bostian KA, Bartelloni PJ, Celia FM, Beisel WR: The effects of Francisella tularensis infection on iron metabolism in man. Am J Med Sci 258: 14–25, 969
Beamish MR, Jones PA, Trevett D, Evans IH, Jacob A: Iron metabolism in Hodgkin's disease. Br J Cancer 26: 444–452
Beisel WR: Trace elements in infectious processes. Med Clin North Am 60: 831–849, 1976
Schade SG: Normal incorporation of oral iron into intestinal ferritin in inflammation. Proc Soc Exp Biol Med 139: 620–622, 1972
Schade SG: Suppressive effect of endotoxin on erythropoietin-responsive cells in mice. Am J Physiol 231: 73–76, 1976
Hershko C, Cook JD, Finch CA: Storage iron kinetics. VI. The effect of inflammation on iron exchange in the rat. Br J Hematol 28: 67–75, 1974
Cartwright GE, Lee GR: The anemia of chronic disorders. Br J Hematol 21: 147–152, 1971
Beresford CH, Neale RJ, Brooks OG: Iron absorption and pyrexia. Lancet 1: 568–575, 1971
Cortell S, Conrad ME: Effect of endotoxin on iron absorption. Am J Physiol 213: 43–47, 1967
Haurani FI, Green D, Young K: Iron absorption in hypoferremia Am J Med Sci 249: 537–547, 1967
Haurani FI, Burke W, Martinez EJ: Defective reutilization of iron in the anemia of inflammation. J Lab Clin Med 65: 56–571, 1965
Crosby DH: The control of iron balance by the intestinal mucosa. Blood 22: 441–449, 1963
Freirich EJ, Miller A, Emerson CP, Ross JF: The effect of inflammation on the utilization of erythrocyte and transferrin bound radioiron for red cell production. Blood 12: 972–983, 1957
Roeser HP: Iron metabolism in inflammation and malignant disease. In: Jacob A, Worwood M (eds) Iron in Biochemistry and Medicine, Academic Press, New York, 1980, pp 605–640
Van Snick JL, Masson PL, Heremans JF: The involvement of lactoferrin in the hyposideremia of acute inflammation. J Exp Med 140: 1068–1084, 1974
Lee GR: The anemia of chronic disease. Semin Hematol 20: 61–80, 1983
Finkelstein RA, Sciortino CV, McIntosh MA: Role of iron in microbe-host interaction. Rev Infect Dis 5: 759–777, 1983
Noyes WD, Bothwell TH, Finch CA: The role of the reticulo-endothelial cell in iron metabolism. Br J Hematol 6: 43–55, 1960
Quastel MR, Ross JF: The effect of acute inflammation on the utilization and distribution of transferrin-bound and erythrocyte radioiron. Blood 28: 738–757, 1966
Konijn AD, Hershko C: Ferritin synthesis in inflammation. I. Pathogenesis of impaired iron release. Br J Hematol 37: 7–16, 1977
Bromford AB, Munro HN: Biosynthesis of ferritin and isoferritins. In. Iron in Biochemistry and Medicine. Academic Press, New York, 1980, pp 173–202
Letendre ED, Holbein BE: Turnover in the transferrin iron pool during the hypoferremic phase of experimental Neisseria meningitidis infection in mice. Infect Immun 39: 50–59, 1983
Letendre ED, Holbein BE: Mechanism of impaired iron release by the RE system during the hypoferremic phase of experimental Neisseria meningitidis infection in mice. Infect Immun 44: 320–325, 1984
White GP, Worwood M, Parry DH, Jacobs A: Ferritin synthesis in normal and leukemic leukocytes. Nature London 250: 584–586, 1974
Glass J, Nunez MT, Fischer S, Robinson H: Transferrin receptors, iron transport and ferritin metabolism in Friend erythroleukemia cells. Biochem Biophys Acta 542: 154–162, 1978
Konijn A, Hershko C, Izak G: Ferritin synthesis in developing erythroid precursor cells. Israel J Med Sci 14: 1181–1185, 1978
Kampschmidt RF: Role of RES and LEM in iron, zinc, and copper metabolism. Adv Exp Med Biol 121A: 403–411, 1980
Kampschmidt RF: Leukocyte endogenous mediator. J Reticuloendothelial Soc 23: 287–297, 1978
Kushner I: The phenomenon of the acute phase response. Ann NY Acad Sci 389: 39–48, 1982
Butter EJ, Curtis MJ, Watford M: The effect of Escherichia coli endotoxin on the plasma iron concentration in the domestic fowl. Res Vet Sci 15: 267–269, 1973
Grieger TA, Kluger MG: Effects of bacteria and temperature on free serum iron levels in the lizard Dipsosaurus dorsalis. Physiologist 20: 37, 1977
Chandlee GC, Fukui GM: The role of endotoxin-induced non-specific protection. Abst Annu Meet Am Soc Microbiol p 45, 1965
Elin RJ, Wolff SM: The role of iron in non-specific resistance to infection induced by endotoxin. J Immunol 112: 737–745, 1973
Kochan I: The role of iron in bacterial infections with special consideration of host-tubercle bacillus interaction. Curr Top Microbiol Immunol 60: 1–30, 1973
Letendre ED, Holbein BE: Ceruloplasmin and regulation of transferrin iron during Neisseria meningitidis infection in mice. Infect Immun 45: 133–138, 1984
Baggs RB, Miller SA: Nutritional iron deficiency as a determinant of host resistance in the rat. J Nutr 103: 1554–1560, 1973
Chu SW, Welch KJ, Murray ES, Hegsted DM: Effect of iron deficiency on the susceptibility to Streptococcus pneumoniae infection in the rat. Nut Rep Int 14: 605–609, 1976
Lee CM, George YG, Aboko-Cole GF: Interaction of nutrition and infection. Int J Biochem 8: 525–529, 1977
Pushmann M, Ganzoni AM: Increased resistance of irondeficient mice to Salmonella infection. Infect Immun 17: 663–664, 1977
Murray MJ, Murray AB: Starvation suppression and refeeding: activation of infection. Lancet i: 123–125, 1977
Murray MJ, Murray MB, Murray CJ: The adverse effect of iron repletion on the course of certain infections. Br Med J ii: 1113–1115, 1978
Nauts HC: Bacterial vaccine therapy for cancer. Develop Biol Standardization 38: 487–494, 1978
Nauts HC: The apparently beneficial effects of bacterial infections on host resistance to cancer: end results in 435 cases. Cancer Res Inst Monographs 8: 1–830, 1980
Pearl R: Cancer and tuberculosis. Am J Hyg 9: 97–159, 1929
Kreider JW, Bartlett GL, Purnell DM: Immunotherapeutic effectiveness of BCG inactivated by various modalities. Cancer 46: 480–487, 1980
Yang C, Nowotny A: Effect of endotoxin on tumor resistance in mice. Infect Immun 9: 95–100
Sword CP: Mechanisms of pathogenesis in Listeria monocytogenes infection. J Bact 92: 536–542, 1966
Milas L, Scott TM: Antitumor activity of Corynebacterium parvum. Adv Cancer Res 26: 257–304, 1978
Bullen JJ, Cushnie GH, Rogers HJ: The abolition of the protective effect of Clostridium welchii type A antiserum by ferric iron. Immunol 12: 303–312, 1967
Bullen JJ, Rogers HJ, Griffiths E: Role of iron in bacterial infections. Curr Top Microbiol Immunol 80: 1–35, 1978
Bullen JJ, Wards CG, Wallis SN: Virulence and the role of iron in Pseudomonas aeruginosa infection. Infect Immun 10: 443–450, 1974
Holbein BE: Enhancement of Neisseria meningitidis infection in mice by addition of iron bound to transferrin. Infect Immun 34: 120–125, 1981
Payne SM, Finkelstein RA: Pathogenesis and immunology of experimental gonococcal infection: role of iron in virulence. Infect Immun 12: 1313–1318, 1975
Melby K, Slordahl S, Gutteberg TJ, Nordbo SA: Septicemia due to Yersinia enterolitica after oral overdoses of iron. Br Med J 285: 467–468, 1982
Holbein BE, Jericho KW, Likes GC: Neisseria meningitidis: infection in mice influence of iron, variations in virulence among strains and pathology. Infect Immun 24: 545–551, 1979
Calver GA, Kenny CP, Lavergne G: Iron as a replacement for mucin in the establishment of meningococcal infection in mice. Can J Microbiol 22: 832–838, 1976
Fusillo MH, Smith JC, Reednick JA: Iron and the mystique of mucin. Abstr Annu Meet Am Soc Microbiol p 73, 1974
Bennett IL, Hook EW: Infectious diseases (some aspects of salmonellosis). Annu Rev Biochem 10: 1–20, 1959
Black PH, Kunz JJ, Swartz MN: Salmonellosis — a review of some unusual aspects. N Engl J Med 262: 811–817, 1960
Rabson AR, Hallett AF, Koornhof HJ: Generalized Yersinia enterolitica infection. J Infect Dis 131: 447–451, 1975
Scott PH, Berger HM, Scott P, Kenwood C, Wharton BA: Effect of gestational age and intrauterine nutrition on plasma transferrin and iron in the newborn. Arch Dis Child 50: 796–798, 1975
Stockman JA: Infections and iron: too much of a good thing? Am J Dis Child 135: 18–20, 1981
Farmer K, Becroft DM: Administration of parenteral iron to newborn infants. Arch Dis Child 51: 486–488, 1976
Murray MJ, Murray AB, Murray NJ, Murray MB: Refeeding malaria and hyperferremia. Lancet i: 653–654, 1975
Murray MJ, Murray AB, Murray NJ, Murray MB: Somali food shelters in the Ogadan famine and their impact on health. Lancet i: 1283–1285, 1976
Robertson MA, Harrington JS, Bradshaw E: The cancer pattern in African gold miners. Br J Cancer 25: 395–402, 1971
Berman C: Primary carcinoma of the liver. Adv Cancer Res 5: 55–96, 1958
Axelson O, Sjoberg AS: Cancer incidence and exposure to iron. Occup Med 21: 419–422, 1979
Bomford A, Williams R: Long-term results of venesection therapy in idiopathic hemochromatosis. Quart J Med 45: 611–623, 1976
Johnson PJ, Krasner N, Portmann B, Eddleston ALWF, Williams R: Hepatocellular carcinoma in Great Britain: influence of age, sex, Hb Ag status and etiology of underlying cirrhosis. Gut 19: 1022–1026
Milder MS, Cook JD, Stray S, Finch CA: Idiopathic hemochromatosis, an interim report. Medicine 59: 34–49, 1980
Purtillo DT, Gottlieb LS: Cirrhosis and hepatoma occurring at Boston City Hospital (1917–1968). Cancer 32: 458–462, 1973
Sherlock S: Hemochromatosis: course and treatment. Annu Rev Med 27: 143–149, 1976
Magnusson G, Flodh H, Malmfors T: Oncological study in rats with Ferastral an iron-polycomplex, after intramuscular administration. Scand J Haematol Suppl 32: 87–98. 1977
Lundin PM: The carcinogenic action of complex iron preparations. Br J Cancer 15: 838–847
Van Asbeck BS, Verbrugh HA, Van Oost BA, Marx JJM, Imhof HW, Verhoef J: Listeria monocytogenes meningitis and decreased phagocytosis associated with iron overload. Br Med J 284: 542–544, 1982
Weinberg JB, Hibbs JB: Endocytosis of red blood cells or hemoglobin by activated macrophages inhibit their tumorcidal effect. Nature London 269: 245–247, 1977
Stich HF, Wei L, Whiting RF: Enhancement of the chromosome-damaging action of ascorbate by transition metals. Cancer Res 39: 4145–4151, 1979
Guille E, Grisvard J, Sissoeff I: Implications of reiterative DNA-metal ion complexes in the induction and development of neoplastic cells. Biol Trace Elem Res 1: 299–311
Tani P: Serum iron, copper, iron-binding capacity and marrow hemosiderin in pulmonary tuberculosis. Ann Med Intern Fenn 54: Suppl. 44: 1–61, 1965
Levine AS, Schimpff SC, Graw RG, Young RC: Hematologic malignancies and other marrow failure states: progress in the management of complicating infections, Semin Hematol 11: 141–202
Trowbridge IS, Domingo DL: Anti-Tf receptor monoclonal antibodies and toxin-antibody conjugates affect growth of human tumor cells. Nature 294: 171–173, 1981
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Letendre, E.D. Iron metabolism during infection and neoplasia. Cancer Metast Rev 6, 41–53 (1987). https://doi.org/10.1007/BF00047608
Issue Date:
DOI: https://doi.org/10.1007/BF00047608